vs

Side-by-side financial comparison of Chemours Co (CC) and VEON Ltd. (VEON). Click either name above to swap in a different company.

Chemours Co is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.2× VEON Ltd.). VEON Ltd. runs the higher net margin — 55.9% vs -3.5%, a 59.5% gap on every dollar of revenue. On growth, VEON Ltd. posted the faster year-over-year revenue change (5.8% vs -2.1%).

The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.

VEON Ltd., also known as VEON Group, is a multinational telecommunication and digital services company. Headquartered in Dubai, the company is publicly traded on the U.S.-based NASDAQ stock exchange. VEON operates in six markets in Europe and Asia, including Bangladesh, Kazakhstan, Kyrgyzstan, Pakistan, Ukraine and Uzbekistan. Specific brands include Banglalink in Bangladesh, Jazz in Pakistan, Kyivstar in Ukraine, and units operating in Kazakhstan, Kyrgyzstan, and Uzbekistan under the Beeline...

CC vs VEON — Head-to-Head

Bigger by revenue
CC
CC
1.2× larger
CC
$1.3B
$1.1B
VEON
Growing faster (revenue YoY)
VEON
VEON
+7.9% gap
VEON
5.8%
-2.1%
CC
Higher net margin
VEON
VEON
59.5% more per $
VEON
55.9%
-3.5%
CC

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CC
CC
VEON
VEON
Revenue
$1.3B
$1.1B
Net Profit
$-47.0M
$608.0M
Gross Margin
11.7%
Operating Margin
75.4%
Net Margin
-3.5%
55.9%
Revenue YoY
-2.1%
5.8%
Net Profit YoY
-261.5%
583.1%
EPS (diluted)
$-0.32
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CC
CC
VEON
VEON
Q4 25
$1.3B
Q3 25
$1.5B
Q2 25
$1.6B
$1.1B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.5B
Q2 24
$1.6B
$1.0B
Q1 24
$1.4B
Net Profit
CC
CC
VEON
VEON
Q4 25
$-47.0M
Q3 25
$46.0M
Q2 25
$-380.0M
$608.0M
Q1 25
$-5.0M
Q4 24
$-13.0M
Q3 24
$-32.0M
Q2 24
$60.0M
$89.0M
Q1 24
$54.0M
Gross Margin
CC
CC
VEON
VEON
Q4 25
11.7%
Q3 25
15.6%
Q2 25
17.2%
Q1 25
17.3%
Q4 24
19.4%
Q3 24
19.0%
Q2 24
19.8%
Q1 24
20.9%
Operating Margin
CC
CC
VEON
VEON
Q4 25
Q3 25
2.5%
Q2 25
-15.4%
75.4%
Q1 25
Q4 24
-0.1%
Q3 24
-2.1%
Q2 24
4.4%
27.1%
Q1 24
5.1%
Net Margin
CC
CC
VEON
VEON
Q4 25
-3.5%
Q3 25
3.1%
Q2 25
-23.5%
55.9%
Q1 25
-0.4%
Q4 24
-1.0%
Q3 24
-2.1%
Q2 24
3.9%
8.7%
Q1 24
4.0%
EPS (diluted)
CC
CC
VEON
VEON
Q4 25
$-0.32
Q3 25
$0.31
Q2 25
$-2.53
$0.34
Q1 25
$-0.03
Q4 24
$-0.07
Q3 24
$-0.22
Q2 24
$0.39
$0.04
Q1 24
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CC
CC
VEON
VEON
Cash + ST InvestmentsLiquidity on hand
$670.0M
$1.3B
Total DebtLower is stronger
$4.1B
Stockholders' EquityBook value
$250.0M
$1.5B
Total Assets
$7.4B
$8.5B
Debt / EquityLower = less leverage
16.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CC
CC
VEON
VEON
Q4 25
$670.0M
Q3 25
$613.0M
Q2 25
$502.0M
$1.3B
Q1 25
$464.0M
Q4 24
$713.0M
Q3 24
$596.0M
Q2 24
$604.0M
$862.0M
Q1 24
$746.0M
Total Debt
CC
CC
VEON
VEON
Q4 25
$4.1B
Q3 25
$4.1B
Q2 25
$4.1B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.0B
Q2 24
$4.0B
Q1 24
$4.0B
Stockholders' Equity
CC
CC
VEON
VEON
Q4 25
$250.0M
Q3 25
$274.0M
Q2 25
$228.0M
$1.5B
Q1 25
$566.0M
Q4 24
$571.0M
Q3 24
$643.0M
Q2 24
$714.0M
$1.1B
Q1 24
$753.0M
Total Assets
CC
CC
VEON
VEON
Q4 25
$7.4B
Q3 25
$7.5B
Q2 25
$7.5B
$8.5B
Q1 25
$7.4B
Q4 24
$7.5B
Q3 24
$7.5B
Q2 24
$7.2B
$7.3B
Q1 24
$8.0B
Debt / Equity
CC
CC
VEON
VEON
Q4 25
16.40×
Q3 25
14.96×
Q2 25
17.99×
Q1 25
7.18×
Q4 24
7.11×
Q3 24
6.20×
Q2 24
5.53×
Q1 24
5.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CC
CC
VEON
VEON
Operating Cash FlowLast quarter
$137.0M
Free Cash FlowOCF − Capex
$92.0M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$51.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CC
CC
VEON
VEON
Q4 25
$137.0M
Q3 25
$146.0M
Q2 25
$93.0M
Q1 25
$-112.0M
Q4 24
$138.0M
Q3 24
$139.0M
Q2 24
$-620.0M
Q1 24
$-290.0M
Free Cash Flow
CC
CC
VEON
VEON
Q4 25
$92.0M
Q3 25
$105.0M
Q2 25
$50.0M
Q1 25
$-196.0M
Q4 24
$29.0M
Q3 24
$63.0M
Q2 24
$-693.0M
Q1 24
$-392.0M
FCF Margin
CC
CC
VEON
VEON
Q4 25
6.9%
Q3 25
7.0%
Q2 25
3.1%
Q1 25
-14.3%
Q4 24
2.1%
Q3 24
4.2%
Q2 24
-44.6%
Q1 24
-28.8%
Capex Intensity
CC
CC
VEON
VEON
Q4 25
3.4%
Q3 25
2.7%
Q2 25
2.7%
Q1 25
6.1%
Q4 24
8.0%
Q3 24
5.0%
Q2 24
4.7%
Q1 24
7.5%
Cash Conversion
CC
CC
VEON
VEON
Q4 25
Q3 25
3.17×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-10.33×
Q1 24
-5.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CC
CC

Titanium Technologies$563.0M42%
Thermal And Specialized Solutions$443.0M33%
Advanced Performance Materials$312.0M23%
Other Non-Reportable Segment$12.0M1%

VEON
VEON

Segment breakdown not available.

Related Comparisons